Pharmatec Engineering ApS: Financial statements 2023
CVR: 37819859
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharmatec Engineering ApS (CVR 37819859) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,703,818 and a net result of DKK 604,813 compared with DKK 258,321 the year before. That is an increase of 27.6% compared with the year before. Equity in the 2023 report amounted to DKK 1,683,290. The solvency ratio was 82.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,703,818
- Profit/Loss
- DKK 604,813
- Equity
- DKK 1,683,290
- Total Assets
- DKK 2,032,181
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.7 mio. | 605 t. | 1.7 mio. | 1 |
| 2022 | - | 1.3 mio. | 258 t. | 1.2 mio. | 1 |
| 2021 | - | 997 t. | 306 t. | 1.1 mio. | 1 |
| 2020 | - | 840 t. | 309 t. | 793 t. | 1 |
| 2019 | - | 528 t. | 58 t. | 556 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmatec Engineering ApS has published its annual report for 2022. Gross profit came to DKK 1,335,545, and the net result was DKK 258,321.
About Pharmatec Engineering ApS
Pharmatec Engineering ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kim Fasting. The company is owned by Kim Fasting. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,380,062 and a net result of DKK 2,278,538 compared with DKK 323,508 the year before. Equity in the 2025 report amounted to DKK 4,028,336.